Canadian marijuana stocks have been the focus of many investors as the country just rang in its official first full week as the world’s second country to legalize recreational marijuana. In line with this, excitement continues to grow around the next big industry to hit the mainstream. It’s no wonder that investor interest has grown either.
Investors are looking to cash in on a new market are seeing first hand, an industry that generated $8.5 billion on legal marijuana in the U.S. last year and which is estimated to grow to $23.4 billion in 2022, according to Arcview Market Research and BDS Analytics. With this being the case, a number of companies are getting involved in some way.
Premier Health Group, Inc. (PHGI.CN) (PHGRF), among other things, is targeting acquisitions of clinics, technology and patients in addition to cannabis clinic(s) and partnerships. The Company completed a CAD $3.55 million financing in August and $1 million was used for the acquisition of HealthVue. The Company currently has no debt and is well capitalized to strategically acquire additional clinics as well as build out new clinics.
HealthVue has been aggressively testing various healthcare technologies and services to gain feedback from patients and healthcare professionals. The research has shown a strong acceptance of the use of 24/7 online booking by patients allowing better access and decreased clinic overhead. HealthVue has also tested telemedicine acceptance in a pilot program and found incredible excitement by all parties.
“Patients have found that connecting with their healthcare professional from the convenience of their work or home to be extremely revolutionary, so much so that many patients in the pilot used the service repeatedly,” said Dr. Essam Hamza, CEO of Premier Health, in a recent press release.
MPX Bioceutical Corporation (MPX.CN) (MPXEF) along with iAnthus Capital Holdings, Inc. (IAN) (ITHUF) recently announced that both companies have signed an arrangement agreement pursuant to which iAnthus will combine with MPX in an all-stock transaction with offered equity consideration to MPX shareholders valued at $835 million before giving effect to MPX International (defined below) and assuming all of MPX’s dilutive securities are exercised prior to the completion of the transaction. The Agreement represents the first public-to-public merger transaction in U.S. cannabis history.
The combined company, excluding MPX International, will encompass operations and cannabis licenses in 10 states that will permit iAnthus to operate 56 retail locations and 14 cultivation/processing facilities.
Aurora Cannabis Inc. (ACB.TO) (ACBFF)’s common shares were approved for listing onto the New York Stock Exchange and began trading effective the open of markets on October 23, 2018. Aurora’s shares trade on the NYSE under ticker symbol “ACB”, the same symbol the Company’s common shares currently, and will continue to, trade under on the Toronto Stock Exchange (TSX). Existing shares of Aurora, which previously traded on the OTCQX under the ticker symbol “ACBFF”, now trade on the NYSE.
“Our NYSE listing represents another important milestone that reflects our commitment to all stakeholders as we continue advancing domestic and international growth initiatives, which includes expanding our base of global institutional and retail investors,” said Terry Booth, CEO of Aurora.
Biotech Breakroom is an affiliate of Midam Ventures LLC. Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. MIDAM was hired for a period from 10/1/2018–4/1/2018 to publicly disseminate information about Premier Health Group Inc. Midam was paid $100,000 (CASH) & “500,000” shares of restricted common shares, they own zero shares that were purchased in the open market. Once the (6) six-month restriction is complete on 4/1/2018, Midam plans to sell the “500,000” shares of Premier Health Group Inc. that they hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Midam may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full Midam disclaimer.